Biktarvy, formally known as bictegravir, includes a effective single-tablet regimen for treating HIV infection. This drug combines three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the HIV's ability to multiply within the body, remarkably decreasing the viral load. For many individua